Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority TrialVanita Noronha, Kumar Prabhash, Vedang Murthy et al.|Journal of Clinical Oncology|2017Cited by 340
Synthesis and Preclinical Evaluation of <sup>177</sup> Lu-CHX-A”-DTPA-Rituximab as a Radioimmunotherapeutic Agent for Non-Hodgkin's LymphomaMythili Kameswaran, Grace Samuel, Ashutosh Dash et al.|Cancer Biotherapy and Radiopharmaceuticals|2015Cited by 23